TBDT (GLSynthesis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTBDT (GLSynthesis)
Drug Alias Nameuroselective calcium antagonists (GL Synthesis)TBDT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlsynthesis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlsynthesis Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A